death from semaglutide FDA Approves to Reduce Kidney Disease, Cardiovascular Risk in Adults With Type 2 Diabetes, Chronic Kidney Disease Semaglutide Weight Loss Injections |
Description
Legal and regulatory issues: Scientists must adhere to strict regulations and guidelines when conducting semaglutide research studies
References Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic Z, et al
doi:10.1038/npp.2013.334
The main issue is that weight loss can worsen this process, as fat is one of the main elements supporting the skin
